Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001651431-19-000004
Filing Date
2019-04-01
Accepted
2019-04-01 09:56:48
Documents
1
Effectiveness Date
2019-04-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11795
  Complete submission text file 0001651431-19-000004.txt   12865
Mailing Address 101 MAIN STREET 14TH FLOOR CAMBRIDGE MA 02142
Business Address 101 MAIN STREET 14TH FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-327684 | Film No.: 19719112